Nasdaq

Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America

C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class ...

Why can’t housing authorities spend their full budget?

Take your real estate business to the next level with TRD Data access. A one-stop resource that provides exclusive access to ...
The Business Journal

Section 8 housing payments continue despite federal shutdown — for now

Despite the federal government shutdown, Section 8 housing payments are continuing as scheduled for the time being. The U.S. Department of Housing and Urban Development (HUD) has committed funding tha ...
Nasdaq

Atea Pharmaceuticals Advances HCV Treatment with Ongoing Phase 3 C-BEYOND Trial and Promising Phase 2 Results for Bemnifosbuvir and Ruzasvir at EASL 2025

Atea Pharmaceuticals announced the ongoing enrollment in its Phase 3 C-BEYOND trial evaluating the combination of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV). Positive ...

Atea Pharmaceuticals to Present New Data Supporting Combination of Bemnifosbuvir and Ruzasvir as Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus I…

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...
NBC Montana

Waiting list for Section 8 housing set to open July 1

HELENA, Mont. — Montana’s waiting list for Section 8 housing choice vouchers opens to applicants next month. The Federal Rental Assistance Program is available for low-income people and households.